Bilberry and lingonberry extracts show eye health potential
Extracts from bilberries and lingonberries may protect the retina in the eye against UV damage, says a new study from Japan.
Archives for October 17, 2013
Integrated data systems help cut cost of GMP compliance, providers say
GMP compliance has been a steep hill to climb for the dietary supplement industry by some accounts. And the advent of the regulations, which took full force for all sectors of industry in June of 2010, wasn’t good news for the nation’s forests as...
High serum omega-3 status linked to lower brain abnormalities in the elderly
A high level of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in blood may lower the risk of small infarcts and other brain abnormalities that are linked to cognitive decline in the elderly, according to new research.
Grape seed extract in beverages shows promise in blood pressure reduction: Study
With two recent studies showing the potential of grape seed extract dispensed in capsules to help reduce blood pressure in people at risk of hypertension, researchers are investigating the effects of that Polyphenolics MegaNatural BP ingredient in...
Kappa Bioscience announces vitamin K2 stability project
Norwegian firm Kappa Bioscience has announced a research project into possible solutions to stability issues concerning vitamin K2, results of which could help manufacturers secure label claims.
Incoherent and uncoordinated EU regulators should worry policy makers and industry
The stop-and-go, uncoordinated approach of EU-level and national regulators to bans on nutritional supplements including DMAA, dexaprine and synephrine, should be a cause for concern among policy makers and industry alike, warns Luca Bucchini, PhD.
Vitamin D does not contribute to kidney stones, says study
Previous research linking vitamin D supplementation to an increased risk of developing kidney stones has been cast in to doubt with new findings that find no statistically relevant association.